KRUSE BO (EVP, CFO, Secy & Treas.) sold 2.2% of their position (4K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $31.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/23/2022ACC: 0001104659-22-026182
DirectorOfficer· EVP, CFO, Secy & Treas.
Since Sep 2018
-4K
Net shares
Net seller
$31.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4K
Price / share
$7.85
Trade value
$31.40K
% of position
2.2%
2/22/2022
185.08K→181.08K
Total
Net shares
−4K
Net value
-$31.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/22/2022 | S · Sale | −4K | $7.85 | $31.40K | 2.2% | 185.08K | 181.08K |
| Total | −4K | -$31.40K | ||||||
Derivative Transactions0
No derivative transactions reported